bioMérieux S.A. (LON:0RUG)
London · Delayed Price · Currency is GBP · Price in EUR 124.25
-0.05 (-0.04%)
At close: Aug 4, 2025
Verve Therapeutics Market Cap
bioMérieux has a market cap or net worth of 12.79 billion as of August 8, 2025. Its market cap has increased by 31.57% in one year.
Market Cap
12.79B
Enterprise Value
12.83B
Revenue
3.29B
Ranking
n/a
PE Ratio
35.79
Stock Price
$124.25
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 788.30M to 12.79B, an increase of 1,522.62%. That is a compound annual growth rate of 14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 12.79B | 26.64% |
| Dec 31, 2024 | 10.10B | -2.05% |
| Dec 29, 2023 | 10.31B | 0.30% |
| Dec 30, 2022 | 10.28B | -17.18% |
| Dec 31, 2021 | 12.41B | 1.48% |
| Dec 31, 2020 | 12.23B | 54.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.41B |
| HSBC Holdings | 161.93B |
| Shell | 160.15B |
| Unilever | 112.48B |
| British American Tobacco p.l.c. | 92.49B |
| Rolls-Royce Holdings | 91.50B |
| Rio Tinto Group | 76.88B |
| RELX PLC | 67.05B |